V CompBrief BY VELARION

Chief Executive Officer · FENNEC PHARMACEUTICALS INC. (FENC)

Jeffrey Hackman

A named executive officer of FENNEC PHARMACEUTICALS in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,722,154

FY2024: $1,611,862

2nd of 3 named executive officers at Fennec Pharmaceuticals by FY2025 total.

3 named officers on file for FENNEC PHARMACEUTICALS, FY2025

See an example →

What this number hides

The filing gives the total. FENNEC PHARMACEUTICALS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Free

Get Jeffrey Hackman’s full pay file as a PDF — free

More than this page: up to 10 years of Jeffrey’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jeffrey Hackman and every company like it: Velarion Intel, free for 3 days, no card →

Jeffrey Hackman compensation by year

FENNEC PHARMACEUTICALS Summary Compensation Table · all 2 fiscal years held
In US dollars, as FENNEC PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$225,000$586,343
Bonus$0$45,833
Stock awards$0$887,100
Option awards$1,386,862$202,878
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$1,611,862$1,722,154

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: FENNEC PHARMACEUTICALS INC. DEF 14A filed April 28, 2026, accession 0001104659-26-050339, and prior-year filings.

How this page was built: the FENNEC PHARMACEUTICALS INC. filed document, accession 0001104659-26-050339. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

$1.6M
$1.7M
FY24
FY25
SalaryBonusStock awardsOption awards

FENNEC PHARMACEUTICALS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert AndradeChief Financial Officer$1,873,024
Jeffrey Hackman · this pageChief Executive Officer$1,722,154
Pierre SayadChief Medical Officer$775,081

The full FENNEC PHARMACEUTICALS compensation record

free company brief
FENNEC PHARMACEUTICALS INC. (FENC) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within FENNEC PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the FENNEC PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order FENNEC PHARMACEUTICALS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are FENNEC PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jeffrey Hackman's compensation dossier